Page last updated: 2024-10-30

metformin and Leukemia, Megakaryocytic

metformin has been researched along with Leukemia, Megakaryocytic in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin has received increasing attention for its potential anticancer activity against certain human leukemia cells, but its effects on human megakaryoblastic cells are unclear."1.46Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells. ( Gao, C; Guo, G; Kong, P; Liang, X; Wang, J; Xu, Y, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liang, X1
Kong, P1
Wang, J1
Xu, Y1
Gao, C1
Guo, G1

Other Studies

1 other study available for metformin and Leukemia, Megakaryocytic

ArticleYear
Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells.
    Journal of pharmacological sciences, 2017, Volume: 135, Issue:1

    Topics: Apoptosis; Cell Line; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Humans;

2017